DrugPatentWatch Database Preview
Organon Usa Inc Company Profile
What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?
ORGANON USA INC has thirty approved drugs.
There are seven US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.
Summary for Organon Usa Inc
| US Patents: | 7 |
| Tradenames: | 32 |
| Ingredients: | 26 |
| NDAs: | 30 |
Drugs and US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | ORGATRAX | hydroxyzine hydrochloride | INJECTABLE;INJECTION | 087014-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Organon Usa Inc | METHYLPREDNISOLONE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 087535-001 | Jun 25, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-002 | Mar 17, 1994 | 4,894,369*PED | ➤ Try a Free Trial |
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-003 | Feb 11, 2004 | 5,767,251 | ➤ Try a Free Trial |
| Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-004 | Feb 11, 2005 | 5,929,028 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Organon Usa Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Ukraine | 89518 | ➤ Try a Free Trial |
| Luxembourg | 91655 | ➤ Try a Free Trial |
| Poland | 346127 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Organon Usa Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 49/2008 | Austria | ➤ Try a Free Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON |
| /2015 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 00221 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
